Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -26.00p -6.25% 390.00p 380.00p 400.00p 410.00p 390.00p 410.00p 29,402 09:06:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.6 15.2 17.6 22.2 262.00

Eco Animal Health Share Discussion Threads

Showing 626 to 650 of 1050 messages
Chat Pages: Latest  30  29  28  27  26  25  24  23  22  21  20  19  Older
DateSubjectAuthorDiscuss
06/5/2016
12:27
Well another 6p today so we could soon reach 400. Interesting point regarding the historical share price Eco has quite a diverse history so it's possible the previous high was before they divested some of their businesses; I'd have to check the dates which I ain't got time to do right now, day job calls.
audigger
06/5/2016
11:39
Indeed we would, though I must say I find this sort of spurious accuracy rather silly. Why not say "around £9". Actually, the share price is vey near to topping it's all time high, (never mind a 52 week high), reached as long ago as 2002. There was clearly a high level of premature optimism then, but now, 14years later, it is much more justified. If I were Peter Lawrence, I think I would be saying to myself that when I do retire and sell some,or all, of my shares I will want to get very much more for them than I could probably have got 14 years ago. So, realising this, I now think that £5 is too modest a target and that £6, 7, or even 8+ is within the realms of possibility, despite the very high p.e implied.
aimingupward2
04/5/2016
11:31
Article below is at this link: hxxp://www.bodyconfidential.com/stocks/time-to-reconsider-eco-animal-health-group-plc-after-reaching-52-week-high/72368/ The stock of Eco Animal Health Group Plc (LON:EAH) hit a new 52-week high and has GBX 897.35 target or 133.00% above today’s GBX 385.13 share price. The 6 months bullish chart indicates low risk for the GBX 245.39 million company. The 1-year high was reported on May, 3 by Barchart.com. If the GBX 897.35 price target is reached, the company will be worth GBX 326.37 million more. The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 1.75% or GBX 6.63 on May 3, hitting GBX 385.13. About 80,400 shares traded hands. Eco Animal Health Group Plc (LON:EAH) has risen 25.12% since October 1, 2015 and is uptrending. It has outperformed by 17.35% the S&P500. ECO Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The company has a market cap of 245.39 million GBP. The principal activity of the Company is the manufacture and supply of animal health products, which is conducted on global scale through a network, including both regional offices and overseas subsidiaries. It has a 50.65 P/E ratio. The Firm has investments in the intellectual property of Aivlosin, which its patented molecule. I think we'd be happy with 897!
audigger
01/5/2016
21:35
Well, yes, good points, Au. The product profile is certainly very encouraging for aivlosin and, as you say, there is perhaps the possibility of regulators requiring this, or something similar, as standard at some time in the future. Tantalising prospect. I hadn't thought of that before. The other products, though, are definitely secondary, not having similar attractions, it seems. So perhaps around £5 is possible for a buyer with patience and a longish term outlook. The barriers to entry for any competitive product to be developed, registered and approved are huge.
aimingupward2
01/5/2016
20:21
£5 was a figure banded about a few years ago. I guess a key question is how to value this kind of business model in terms of the earnings potential arising from registrations gained (and paid for) but for which sales have yet to be realised. Is the PE ratio a suitable basis for valuation? Another Point to consider is that if Aivlosin does represent a step change in product profile for an antibiotic given to farm animals with its low residue profile, short half-life and clinically effective at low doses such that regulators stipulate future products have to be this way, then there's further significant upside.
audigger
01/5/2016
19:33
So, without getting too carried away, what do you reckon is a realistic sell out price, folks? It's already on a pretty high p.e. remember - probably around 30 for the year just started, so even if you allow for a halving of that by a buyer with it's own sales force(s) making appreciably higher margins, there's not a lot of headroom - is there? Does anyone know if Peel Hunt have had a shot at a figure?
aimingupward2
01/5/2016
19:21
Yes audigger, so Peter Lawrence is not going to give this business away! Exciting times, hopefully
smelleroo
01/5/2016
17:07
Approaching 70 after many years building a profitable company and with his family financially secure, now must be the time to be selling out or planning his succession. Added to this, Eco has now secured registrations in its key target markets and is primed for years of sustained growth. An ideal time to sell the business!
audigger
01/5/2016
12:22
You're welcome. Perhaps it won't be a matter of age, but one of when the company's on-going prospects look brightest.
aimingupward2
01/5/2016
10:50
Thanks! Didn't realise he was that age......that's even more interesting
smelleroo
01/5/2016
09:21
Peter Lawrence was born in 1948, so is 68. Perhaps he'll sell out out and retire at 70, who knows.
aimingupward2
01/5/2016
09:10
Nice move late on Friday! Share price suggests that things are going well for Eco however cannot help feel that developments in North America both achieved by the company but also the change in use of antibiotics is attracting interest! Obv there has been no formal approach otherwise we would know. I am expecting the results to be decent albeit a wee while to go for those. There does seem to be a seller but seller seems to be a provider of liquidity rather than an overhang. Tbh,there are some large, long standing shareholders here So the odd 250k isn't much for them I guess. I was trying to see how old or young Peter Lawrence is. I think he is only around 50 so maybe a it early to it his feet up but you never know! My few shares here won't afford me the same luxury :(
smelleroo
29/4/2016
18:28
Always tempting to sell. I'm going to hold on a bit. If I had more invested I would have top sliced though.
topvest
29/4/2016
17:12
Well last night I decided that today I would sell half my holding which would have returned my original investment leaving the rest as profit. However, I changed my mind at the last minute as I can't help thinking there is an offer coming. Pleased I did given another 5p was added and some late buys declared. Perhaps. May get an RNS next week.....and another 20p rise!
audigger
29/4/2016
16:37
Suddenly, half a million shares bought in the closing minutes - an exact repeat of the other day with 250K followed rapidly by three lots of 83.5K. What's going on I wonder?
aimingupward2
28/4/2016
17:36
Another day, another penny rise. Unfortunately I bought most of my EAH shares prior to being allowed to have AIM shares in an ISA so I need to do some CGT planning. May have to give some shares to the Mrs. Nice problem to have though....
audigger
28/4/2016
11:09
Usually late July or early August. Post Brexit! Sorry shouldn't mention politics!
audigger
28/4/2016
10:36
Guess there is a seller however I am encouraged that the price is moving UP and not DOWN ! When are results from Eco, anyone know?
smelleroo
28/4/2016
10:10
Well, just maybe. But these shares are tightly held and it doesn't take much buying to push the price up. On the other hand somebody acquired 250,000 recently without moving the price. How did they do that?
aimingupward2
27/4/2016
15:44
I think that any acquirer will be starting to make noises to be ahead of the pack! They will defo want aivlosin and be able to take out the central costs as well as having its own distribution. But agree something is likely to be up, just like the share price
smelleroo
27/4/2016
15:10
I'm beginning to wonder if they are in discussions about selling the company as the share price just keeps heading north. Either that or someone is in the know about revenues markedly exceeding expectations. The mysterious peel hunt note may enlighten us. Whatever the driver, long may it continue!
audigger
27/4/2016
09:09
Any buying back by the company would be announced to the market the day after. I am still trying to find the notes from peel hunt on Eco as they are v keen! Cannot find anything on the Internet
smelleroo
27/4/2016
08:25
It may, of course be institutional buying, but I had wondered whether the company might buy some more of it's own shares. Very few have been bought since authorisation to do was put in place.
aimingupward2
27/4/2016
08:12
Well spotted, I hadn't picked up on that news. Another tick up to start the day. The article confirms that they have a zero day withholding period in the USA but I still haven't been able to confirm whether or not this is now the case in the EU. Will do some digging!
audigger
27/4/2016
07:47
Pharmgate Animal Health launches Aivlosin 17% Tylvalosin Apr 26, 2016 Ileitis can have a serious impact on swine producers’ profitability. Ileitis, particularly the chronic form, remains widespread on many swine operations, resulting in poor feed conversion and weight gains. Clinical signs may be subtle or absent; diagnosis by serology or polymerase chain reaction will confirm the presence of the disease. Veterinarians and producers can improve production performance through pig flow management and targeted treatment to reduce this form of the disease, a costly threat. Aivlosin 17% Tylvalosin Type A Medicated Article from Pharmgate Animal Health administered as a sole ration in the feed is effective in reducing clinical signs, mortality, intestinal lesions and performance suppression associated with porcine proliferative enteritis associated with Lawsonia intracellularis infection in swine where the disease has become endemic in groups of pigs in a house or on a farm Under the prescription of a veterinarian, Aivlosin 17% is administered at a level of 38.6 grams per ton in complete finished feed for 14 consecutive days to provide 2.125 milligrams tylvalosin per kilogram body weight daily, offering both a low therapeutic dose rate and short medication duration. No withdrawal period is required, a great benefit when breakdowns occur in late finishers. Furthermore, the clinical efficacy, low therapeutic dose rate, and brief treatment duration are all in accordance with best practices for contemporary commercial swine units and judicious antibiotic use Dan Rosener, technical services director for Pharmgate Animal Health, North America, summarizes it all: “Where Aivlosin Water Soluble Granules has met with widespread acclaim from veterinarians and producers in North America for its fast speed of action in the face of an outbreak, the launch of Aivlosin 17% now allows veterinarians greater flexibility when dealing with the control of subclinical, chronic cases of ileitis. Field efficacy and improved clinical results have been demonstrated since the launch two years ago in Canada. With global concerns about the use of antibiotics, this new medication option, with its low medication dose rate, short treatment time and zero-day withdrawal period fulfills the requirements for the judicious use of antimicrobials in modern pig production.”
smelleroo
Chat Pages: Latest  30  29  28  27  26  25  24  23  22  21  20  19  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190717 16:44:50